102 related articles for article (PubMed ID: 9093523)
1. Collagen: scaffold for repair or execution.
Jensen LT; Høst NB
Cardiovasc Res; 1997 Mar; 33(3):535-9. PubMed ID: 9093523
[No Abstract] [Full Text] [Related]
2. Diurnal variations in serum and urine markers of type I and type III collagen turnover in children.
Wolthers OD; Heuck C; Heickendorff L
Clin Chem; 2001 Sep; 47(9):1721-2. PubMed ID: 11514416
[No Abstract] [Full Text] [Related]
3. Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations.
Stevenson HP; Leslie H; Sheridan B
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():317-8. PubMed ID: 9158832
[No Abstract] [Full Text] [Related]
4. Changes in markers of bone collagen turnover in toxic and euthyroid states: a study of 22 patients.
Wilkinson H; Horsely E
Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():454-5. PubMed ID: 8888980
[No Abstract] [Full Text] [Related]
5. Monitoring tissue repair and fibrosis from a distance.
Weber KT
Circulation; 1997 Oct; 96(8):2488-92. PubMed ID: 9355880
[No Abstract] [Full Text] [Related]
6. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis.
Ono S; Imai T; Shimizu N; Nakayama M; Yamano T; Tsumura M
Eur Neurol; 2000; 44(1):49-56. PubMed ID: 10894996
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen in chronic liver disease.
Hayasaka A; Iida S; Ohto M
Clin Chim Acta; 1995 Jun; 238(1):85-90. PubMed ID: 7554298
[No Abstract] [Full Text] [Related]
8. Method-specific differences in β-isomerised carboxy-terminal cross-linking telopeptide of type I collagen and procollagen type I amino-terminal propeptide using two fully automated immunoassays.
Wheater G; Goodrum C; Tuck SP; Datta HK; van Laar JM
Clin Chem Lab Med; 2014 Jul; 52(7):e135-8. PubMed ID: 24566364
[No Abstract] [Full Text] [Related]
9. Dupuytren's disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagen.
Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
Clin Exp Rheumatol; 2000; 18(2):215-9. PubMed ID: 10812494
[TBL] [Abstract][Full Text] [Related]
10. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum levels of pro-type I collagen peptide, pro-type III collagen peptide and type IV 7S collagen with cervical maturation.
Kanayama N; Terao T
Gynecol Obstet Invest; 1992; 34(1):24-6. PubMed ID: 1526527
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
Akimoto S; Akakura K; Shimazaki J
Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids.
Wolthers OD; Heuck C; Ternowitz T; Heickendorff L; Nielsen HK; Frystyk J
Dermatology; 1996; 192(4):337-42. PubMed ID: 8864369
[TBL] [Abstract][Full Text] [Related]
15. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer.
Keskikuru R; Kataja V; Kosma VM; Eskelinen M; Uusitupa M; Johansson R; Risteli L; Risteli J; Jukkola A
Anticancer Res; 1999; 19(5C):4481-4. PubMed ID: 10650796
[TBL] [Abstract][Full Text] [Related]
16. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y
Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of extracellular matrix in acute pancreatitis.
Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S
Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198
[TBL] [Abstract][Full Text] [Related]
18. Relationships between several markers of extracellular matrix turn-over and ultrasonography in human Schistosomiasis mansoni.
Ricard-Blum S; Hartmann DJ; Grenard P; Ravaoalimalala VE; Boisier P; Esterre P
Am J Trop Med Hyg; 1999 Apr; 60(4):658-63. PubMed ID: 10348244
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
[TBL] [Abstract][Full Text] [Related]
20. Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer.
Ylisirniö S; Sassi ML; Risteli J; Turpeenniemi-Hujanen T; Jukkola A
Anticancer Res; 1999; 19(6C):5577-81. PubMed ID: 10697621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
